1. Home
  2. PCRX vs CSIQ Comparison

PCRX vs CSIQ Comparison

Compare PCRX & CSIQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$23.78

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Canadian Solar Inc. (ON)

CSIQ

Canadian Solar Inc. (ON)

HOLD

Current Price

$13.41

Market Cap

824.4M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCRX
CSIQ
Founded
2006
2001
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
824.4M
IPO Year
2010
2006

Fundamental Metrics

Financial Performance
Metric
PCRX
CSIQ
Price
$23.78
$13.41
Analyst Decision
Strong Buy
Hold
Analyst Count
4
10
Target Price
$30.25
$17.36
AVG Volume (30 Days)
518.7K
2.5M
Earning Date
05-07-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
107.44
N/A
EPS
0.16
N/A
Revenue
$541,533,000.00
N/A
Revenue This Year
$6.78
$23.95
Revenue Next Year
$8.54
$13.58
P/E Ratio
$150.19
N/A
Revenue Growth
26.04
N/A
52 Week Low
$18.80
$6.85
52 Week High
$27.99
$34.59

Technical Indicators

Market Signals
Indicator
PCRX
CSIQ
Relative Strength Index (RSI) 57.59 42.35
Support Level $23.74 $12.22
Resistance Level $23.94 $13.73
Average True Range (ATR) 0.73 0.76
MACD 0.11 0.15
Stochastic Oscillator 75.36 56.16

Price Performance

Historical Comparison
PCRX
CSIQ

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

About CSIQ Canadian Solar Inc. (ON)

Canadian Solar Inc is a Canadian solar technology and renewable energy company. It is a manufacturer of solar photovoltaic modules, a provider of battery energy storage solutions, and a developer of utility-scale solar power and battery energy storage projects.. It operates through two business segments CSI Solar and Recurrent Energy segment. The CSI Solar segment focused on solar modules and battery energy storage manufacturing and products. Its Recurrent segment focused on utility-scale solar power and battery energy storage project development and operation. Key revenue is generated from CSI Solar segment.

Share on Social Networks: